About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Mbnl2tm1.1Sws
targeted mutation 1.1, Maurice W Swanson
MGI:5616630
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws involves: 129S1/SvImJ * BALB/cJ * C57BL/6J MGI:5616633
ht2
Mbnl2tm1.1Sws/Mbnl2+ involves: 129S1/SvImJ * BALB/cJ * C57BL/6J MGI:5616651
cx3
Mbnl1tm1Sws/Mbnl1tm1Sws
Mbnl2tm1.1Sws/Mbnl2+
involves: 129S1/Sv * 129S1/SvImJ * C57BL MGI:5616747
cx4
Mbnl1tm1Sws/Mbnl1+
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
involves: 129S1/Sv * 129S1/SvImJ * C57BL MGI:5616748
cx5
Mbnl1tm1Sws/Mbnl1tm1Sws
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
involves: 129S1/Sv * 129S1/SvImJ * C57BL MGI:5616746


Genotype
MGI:5616633
hm1
Allelic
Composition
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
Genetic
Background
involves: 129S1/SvImJ * BALB/cJ * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mbnl2tm1.1Sws mutation (0 available); any Mbnl2 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• small at weaning, but normal weight by P29

behavior/neurological
• males exhibit increased susceptibility to pentylenetetrazole (PTZ) induced seizures, showing enhanced incidence of tonic-clonic and clonic seizures and die less than 5 min post-PTZ injection following a generalized tonic-clonic seizure or are in a postictal state for more than 30 min
• females exhibit increased susceptibility to PTZ induced seizures also, however with an increased latency compared to males
• mutants learn to locate the hidden platform over the training period in the Morris water maze, however upon platform removal, mutants cross over the location of the platform fewer times than wild-type mice, indicating impaired spatial reference memory
• change in REM sleep is also seen during rebound sleep after a 6 hour sleep deprivation period initiated at ZT0, where a more profound REM sleep rebound is seen in mutants compared to wild-type mice
• no changes in wake and NREM sleep are seen at baseline or during sleep rebound
• males show an increase in REM sleep amounts, associated with increased numbers of REM sleep episodes and increased EEG theta power, most prominent during the dark period
• a larger portion of dark period REM sleep episodes exhibit a short latency from the preceding wake episodes
• males exhibit modest wake fragmentation during dark periods (frequent/shorter wake episodes)
• about 10% of males exhibit extreme hyperactivity prior to weaning followed by tonic-clonic seizures and death within 24 hours

nervous system
• males exhibit increased susceptibility to pentylenetetrazole (PTZ) induced seizures, showing enhanced incidence of tonic-clonic and clonic seizures and die less than 5 min post-PTZ injection following a generalized tonic-clonic seizure or are in a postictal state for more than 30 min
• females exhibit increased susceptibility to PTZ induced seizures also, however with an increased latency compared to males
• about 10% of males exhibit extreme hyperactivity prior to weaning followed by tonic-clonic seizures and death within 24 hours
• males exhibit impaired hippocampal synaptic plasticity
• NMDA receptor-mediated synaptic potentials are reduced in CA1 of the hippocampus
• males exhibit reduced NMDAR excitatory postsynaptic potential (EPSP) amplitude
• pattern stimulation does not induce LTP in mutants

mortality/aging
• about 10% of males exhibit extreme hyperactivity prior to weaning followed by tonic-clonic seizures and death within 24 hours

muscle
N
• mice do not develop overt skeletal muscle pathology or motor deficits prior to 6 months of age and myotonia is absent




Genotype
MGI:5616651
ht2
Allelic
Composition
Mbnl2tm1.1Sws/Mbnl2+
Genetic
Background
involves: 129S1/SvImJ * BALB/cJ * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mbnl2tm1.1Sws mutation (0 available); any Mbnl2 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• males exhibit increased susceptibility to pentylenetetrazole (PTZ) induced seizures

nervous system
• males exhibit increased susceptibility to pentylenetetrazole (PTZ) induced seizures




Genotype
MGI:5616747
cx3
Allelic
Composition
Mbnl1tm1Sws/Mbnl1tm1Sws
Mbnl2tm1.1Sws/Mbnl2+
Genetic
Background
involves: 129S1/Sv * 129S1/SvImJ * C57BL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mbnl1tm1Sws mutation (2 available); any Mbnl1 mutation (39 available)
Mbnl2tm1.1Sws mutation (0 available); any Mbnl2 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice do not survive beyond 23 weeks of age

growth/size/body
• hearts are enlarged and heart/body weight ratios are increased about 60%
• body weight is maintained at about 30% less than single Mbnl1 homozygotes

behavior/neurological
• 8-10 week old mice develop severe mobility problems
• 8-10 week old mice show impaired rotarod performance
• muscle weakness is seen as early as 4 weeks of age in the grip strength test

cardiovascular system
• hearts are enlarged and heart/body weight ratios are increased about 60%
• fibrosis is seen in enlarged right atria
• interstitial myocardial fibrosis
• PR interval is prolonged, indicating a first degree AV block

muscle
• increased muscle fiber size variation, atrophic and splitting fibers, and increased numbers of central nuclei indicative of muscle degeneration/regeneration are seen in muscles at 10-16 weeks of age
• myotonia is increased compared to single Mbnl1 homozygotes, with both the amplitude and duration of discharges increased 2.5 to about 4-fold
• however, the ejection fraction is not different from wild-type mice
• progressive muscle weakness and wasting

nervous system
• loss of mature neuromuscular junctions, and an increase in degenerated (fragmented endplates) and premature neuromuscular junctions in tibialis anterior muscles

cellular
• interstitial myocardial fibrosis

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
myotonic disease DOID:450 J:218011




Genotype
MGI:5616748
cx4
Allelic
Composition
Mbnl1tm1Sws/Mbnl1+
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
Genetic
Background
involves: 129S1/Sv * 129S1/SvImJ * C57BL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mbnl1tm1Sws mutation (2 available); any Mbnl1 mutation (39 available)
Mbnl2tm1.1Sws mutation (0 available); any Mbnl2 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• reduction in embryonic viability




Genotype
MGI:5616746
cx5
Allelic
Composition
Mbnl1tm1Sws/Mbnl1tm1Sws
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
Genetic
Background
involves: 129S1/Sv * 129S1/SvImJ * C57BL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mbnl1tm1Sws mutation (2 available); any Mbnl1 mutation (39 available)
Mbnl2tm1.1Sws mutation (0 available); any Mbnl2 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• time of lethality not specified





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory